Jennifer L. Keating

Jennifer Keating represents clients in a wide range of transactions and in general corporate law matters. Her transactional practice is focused on domestic and cross-border stock and asset acquisitions and divestitures, mergers, joint ventures and minority investments. She also advises clients in strategic commercial matters such as co-development agreements and other collaborative arrangements. Jennifer works with clients in a number of industries, including technology, financial services, chemicals, consumer products and manufacturing.

Jennifer is ranked as a leading Corporate/M&A lawyer in Chambers USA and has been recognized by The Deal as one of its “Top Women in Dealmaking”.

Jennifer is a partner in Mayer Brown’s Chicago office and co-leader of the firm’s global Corporate & Securities practice. She also serves as a member of the firm's Management Advisory Board. Prior to joining Mayer Brown, she served as law clerk to the Honorable James B. Loken of the United States Court of Appeals for the Eighth Circuit.

• Represented Morningstar in various transactions, including its strategic alliance with AssetMark involving the sale of approximately $12 billion in assets from the Morningstar Wealth Turnkey Asset Management Platform, and Morningstar’s acquisition of S&P’s Leveraged Commentary & Data business and related family of leveraged loan indexes for up to $650 million.
• Represented Wolters Kluwer in various matters, including its $415 million acquisition of Registered Agent Solutions, Inc., its acquisition of Vanguard Software Corporation, a global provider of cloud-based integrated business planning solutions, its acquisition of eOriginal, a leading provider of cloud-based digital lending software, and the sale of its Corsearch trademark solutions business to Audax Private Equity.
• Represented Unilever in its acquisition of mens’ personal care brand Dr. Squatch and its acquisition of premium biotech haircare brand K18.
• Represented Hemlock Semiconductor in the acquisition of DuPont's trichlorosilanes (TCS) business, and the acquisition by Corning of DuPont's equity interest in Hemlock, for $725 million.

• The University of Chicago Law School, JD, with honors
  Topic Access Editor, The University of Chicago Law Review
• Cornell University, BA

• Illinois